Zhang et al. postulated that the PNI, which integrates the domains of nutrition, immunology, and inflammation—critical factors in DN—may provide a more reliable prognostic indicator for end-stage renal disease (ESRD) in DN patients compared to traditional markers such as serum albumin levels, inflammatory indices, or lymphocyte counts [9]. The gene discussed is ALB; the disease is stage 5 chronic kidney disease.